Upstream of RAS, endogenous mitogens such as epidermal growth factor (EGF), that are enriched in the tumor microenvironment, bind to cell surface receptor tyrosine kinases (RTKs) and activate a cascade of events, starting with removal of GDP from WT RAS isozymes by guanine nucleotide exchange factors (GEFs). This evidence concerns the gene EGF and neoplasm.